Not all sufferers with CLL call for therapy. Despite all modern advancements, the iwCLL even now suggests watchful observation for sufferers with asymptomatic illness.86 This advice relies on no less than two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Deep, qualifi… Read More